Swiss drugmaker Novartis is betting on heart drug prospect inclisiran in a $9.7 billion takeover of The Medicines Co as it challenges cardiovascular medicines from Amgen Inc , Sanofi and Regeneron Pharmaceuticals .
Source:: Reuters – Business News
Newswire
- [ October 11, 2024 ] New World Solutions (CSE: NEWS) (OTC: REGRF) Appoints Capital Markets Veteran Martin Tremblay to Board of Directors Newsmakers
- [ October 9, 2024 ] Leaders in The News: FuelCell Energy, WeightWatchers, NUBURU, New World Solutions News Feed
- [ October 9, 2024 ] NUBURU (NYSE: BURU) Partners with CDME at Ohio State University to Showcase the Unique Advantages of Blue Wavelength Lasers in Additive Manufacturing Newsmakers
- [ October 9, 2024 ] WeightWatchers (NASDAQ: WW) Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications Newsmakers
- [ October 8, 2024 ] ACHR, BPTH, PLUG, REGRF: Leaders Report Latest Advances in Electric Aviation, Obesity Treatment, Clean Energy and Digital Transformation of $31 Billion Watch Market News Feed
- [ October 8, 2024 ] Archer (NASDAQ: ACHR) Surpasses 400 Test Flights This Year, Achieving Company Milestone Four Months Ahead Of Schedule Newsmakers
- [ October 8, 2024 ] Bio-Path Holdings (NASDAQ:BPTH) Initiates Development of Therapeutic Program for Treatment of Obesity Newsmakers
- [ October 7, 2024 ] SemiCab (NASDAQ: RIME)Wins Contract with $200 Billion Global Consumer Packaged Goods Company for New US Pilot Newsmakers
- [ October 7, 2024 ] LogicMark (NASDAQ: LGMK) Announces Second Quarter 2024 Financial Results; Expansion Strategy into Personal Safety Markets Continues Newsmakers
- [ October 7, 2024 ] LAZR, LGMK, RIME, REGRF: Leaders Report Latest Advances in AI Transformation, Rolex Watch Market, LiDAR, and HealthTech for Aging News Feed
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.